Investor · Pleasanton, CA
Mark Baum
Open Mark in the network graph →Filings
37
SEC Form D
Connections
174
co-filers
Capital
$53.1M
across filings
Active
Jul 2019
to Aug 2021
Most-connected co-filers (174)
Andrew Boll · San Diego, CA16 sharedKamran Hosseini · Pleasanton, CA14 sharedAdrienne A. Graves · Pleasanton, CA12 sharedJ. A. Corley · Pleasanton, CA11 sharedShelley A. Thunen · Pleasanton, CA10 sharedRichard Lindstrom · San Diego, CA10 sharedJames Keller · Palo Alto, CA7 sharedTimothy Collier · New York, NY7 sharedBrian Harper · New York, NY7 sharedMichael Fitzmaurice · New York, NY7 sharedJohn A. Allison · PRINCETON, NJ7 sharedRaymond Merk · Southfield, MI7 sharedGreg Reichow · Waltham, MA7 sharedAnna Z. Boni · Berwyn, PA7 sharedJohn Berdahl · SIOUX FALLS, SD6 sharedMichael Mccarthy · San Diego, CA6 sharedDavid V. Crowder · Palo Alto, CA6 sharedR2G Venture Llc · New York, NY5 sharedR2G Venture Llc · New York, NY5 sharedR2G Manager Llc · New York, NY5 sharedJesse Hom · New York, NY5 sharedJon Baugher · Seattle, WA5 sharedG. S. Greenburg · Seattle, WA5 sharedDaniel O'Mahony · Sunnyvale, CA5 shared
Recent filings (37)
Surface Ophthalmics, Inc.Aug 2021 · 20 co-filers$30.6MRGMZ REIT Subsidiary LLCJul 2021 · 16 co-filers$125KSurface Ophthalmics, Inc.Jul 2021 · 20 co-filers$30.0MSurface Ophthalmics, Inc.Jun 2021 · 20 co-filers$30.0MHARROW HEALTH, INC.May 2021 · 11 co-filers$10.7MHARROW HEALTH, INC.May 2021 · 11 co-filers$10.7MTel-12 REIT LLCMay 2021 · 16 co-filers$125KOrla Mining Ltd.Apr 2020 · 26 co-filers$394KEton Pharmaceuticals, Inc.Apr 2020 · 11 co-filers$7.5MEton Pharmaceuticals, Inc.Apr 2020 · 11 co-filers$7.5MT&C Crossing R2G REIT LLCJan 2020 · 19 co-filers$125KOrla Mining Ltd.Jan 2020 · 29 co-filers$1.9MCoral Creek R2G REIT LLCJan 2020 · 19 co-filers$125KCrossroads R2G REIT LLCJan 2020 · 19 co-filers$125KMission Bay R2G REIT LLCJan 2020 · 19 co-filers$125KOld Orchard R2G REIT LLCJan 2020 · 19 co-filers$125KOrla Mining Ltd.Jul 2019 · 19 co-filers$190KMelt Pharmaceuticals, Inc.Apr 2019 · 14 co-filers$25.8MMelt Pharmaceuticals, Inc.Feb 2019 · 14 co-filers$25.8MPQ Bypass, Inc.Jan 2019 · 9 co-filers$75.2MSurface Pharmaceuticals, Inc.May 2018 · 11 co-filers$20.0MSurface Pharmaceuticals, Inc.May 2018 · 11 co-filers$20.0MProSmart Enterprises Inc.May 2018 · 16 co-filers$199KPQ Bypass, Inc.Feb 2018 · 17 co-filers$300KGreenbriar Equity Fund IV-A, L.P.Oct 2017 · 14 co-filers$1.0B
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Mark in the interactive graph →